Dr. Morie Gertz reviewed Waldenstrom's macroglobulinemia, noting M spike, hyperviscosity, and lymphoplasmacytic cells. Treatments include rituximab-bendamustine and BTK inhibitors, with Zanubrutinib favored for lower toxicity. Patient input and individual factors guide therapy choices.